122 related articles for article (PubMed ID: 38701695)
1. Aggregation of melanoma tumour site within Western Australian families.
Ward SV; Drill EN; Begg CB
Cancer Epidemiol; 2024 Jun; 90():102580. PubMed ID: 38701695
[TBL] [Abstract][Full Text] [Related]
2. The aggregation of early-onset melanoma in young Western Australian families.
Ward SV; Dowty JG; Webster RJ; Cadby G; Glasson EJ; Heyworth JS; Emery J; Cole JM; Millward MJ; Wood FM; Palmer LJ
Cancer Epidemiol; 2015 Jun; 39(3):346-52. PubMed ID: 25843692
[TBL] [Abstract][Full Text] [Related]
3. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
[TBL] [Abstract][Full Text] [Related]
4. The Western Australian Melanoma Health Study: study design and participant characteristics.
Ward SV; Cadby G; Lee A; Cole JM; Heyworth JS; Millward MJ; Wood FM; Palmer LJ
Cancer Epidemiol; 2011 Oct; 35(5):423-31. PubMed ID: 21474410
[TBL] [Abstract][Full Text] [Related]
5. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
[TBL] [Abstract][Full Text] [Related]
6. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.
Cadby G; Ward SV; Cole JM; Moses EK; Millward M; Palmer LJ
Br J Dermatol; 2014 Apr; 170(4):851-7. PubMed ID: 24405011
[TBL] [Abstract][Full Text] [Related]
7. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
9. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.
Hemminki K; Zhang H; Czene K
Int J Cancer; 2003 May; 104(6):764-71. PubMed ID: 12640685
[TBL] [Abstract][Full Text] [Related]
10. Etiology of familial aggregation in melanoma and squamous cell carcinoma of the skin.
Lindström LS; Yip B; Lichtenstein P; Pawitan Y; Czene K
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1639-43. PubMed ID: 17684139
[TBL] [Abstract][Full Text] [Related]
11. Juvenile melanomas: Western Australian Melanoma Advisory Service experience.
Xu JX; Koek S; Lee S; Hanikeri M; Lee M; Beer T; Saunders C
Australas J Dermatol; 2017 Nov; 58(4):299-303. PubMed ID: 28809039
[TBL] [Abstract][Full Text] [Related]
12. A population-based study of Australian twins with melanoma suggests a strong genetic contribution to liability.
Shekar SN; Duffy DL; Youl P; Baxter AJ; Kvaskoff M; Whiteman DC; Green AC; Hughes MC; Hayward NK; Coates M; Martin NG
J Invest Dermatol; 2009 Sep; 129(9):2211-9. PubMed ID: 19357710
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of
Sargen MR; Pfeiffer RM; Elder DE; Yang XR; Goldstein AM; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):676-681. PubMed ID: 33811164
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Sex-Specific Incidence of Melanoma.
Olsen CM; Thompson JF; Pandeya N; Whiteman DC
JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
[TBL] [Abstract][Full Text] [Related]
15. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
16. Melanoma-prone families: new evidence of distinctive clinical and histological features of melanomas in CDKN2A mutation carriers.
Gironi LC; Colombo E; Pasini B; Giorgione R; Farinelli P; Zottarelli F; Esposto E; Zavattaro E; Allara E; Ogliara P; Betti M; Dianzani I; Savoia P
Arch Dermatol Res; 2018 Dec; 310(10):769-784. PubMed ID: 30218143
[TBL] [Abstract][Full Text] [Related]
17. Familial and attributable risks in cutaneous melanoma: effects of proband and age.
Hemminki K; Zhang H; Czene K
J Invest Dermatol; 2003 Feb; 120(2):217-23. PubMed ID: 12542525
[TBL] [Abstract][Full Text] [Related]
18. Comparison between familial and sporadic cutaneous melanoma in Valencia, Spain.
Nagore E; Botella-Estrada R; Garcia-Casado Z; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):931-6. PubMed ID: 18355200
[TBL] [Abstract][Full Text] [Related]
19. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
20. Population-based analysis of prognostic factors and survival in familial melanoma.
Florell SR; Boucher KM; Garibotti G; Astle J; Kerber R; Mineau G; Wiggins C; Noyes RD; Tsodikov A; Cannon-Albright LA; Zone JJ; Samlowski WE; Leachman SA
J Clin Oncol; 2005 Oct; 23(28):7168-77. PubMed ID: 16192601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
